Information Provided By: 
Fly News Breaks for June 21, 2016
SYK, ZBH
Jun 21, 2016 | 06:03 EDT
Piper Jaffray analyst Matt O'Brien encourages investors to buy shares of Zimmer Biomet Holdings (ZBH) into next month's Q2 results. After speaking with contract manufacturer contacts in the orthopedic industry, O'Brien believes the volume strength seen in Q1 continued in Q2. He points out that Zimmer's multiple is roughly 25% lower than peer Stryker (SYK). The analyst has an Overweight rating on Zimmer with a $125 price target.
News For ZBH;SYK From the Last 2 Days
There are no results for your query ZBH;SYK
